PAPILLARY THYROID CANCER
Clinical trials for PAPILLARY THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY THYROID CANCER trials appear
Sign up with your email to follow new studies for PAPILLARY THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blue dye could make thyroid cancer surgery safer and more effective
Disease control Not yet recruitingThis study tests whether injecting a blue dye (mitoxantrone) into the thyroid during robotic surgery helps surgeons remove more cancerous lymph nodes while protecting the parathyroid glands. About 114 adults with papillary thyroid cancer will be randomly assigned to get the dye o…
Matched conditions: PAPILLARY THYROID CANCER
Phase: PHASE4 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
New genetic test aims to reduce unnecessary thyroid surgeries
Diagnosis Not yet recruitingThis study looks at whether a genetic test called Thyroid GuidePx® can help doctors and patients with papillary thyroid cancer make better treatment choices. About 85 adults with small thyroid tumors and no signs of spread will take the test before surgery. Researchers will see i…
Matched conditions: PAPILLARY THYROID CANCER
Sponsor: University of Calgary • Aim: Diagnosis
Last updated May 15, 2026 12:07 UTC